Retracted : Synthesis, Characterization, and In vitro Studies of PLGA – PEG Nanoparticles for Oral Insulin Delivery (Chemical Biology & Drug Design, (2014), 84, 3, (307-315), 10.1111/cbdd.12318);Synthesis, characterization, and in vitro studies of PLGA-PEG nanoparticles for oral insulin delivery

Chemical Biology and Drug Design

Volumn 84, Issue 3, 2014, Pages 307-315

  Hosseininasab, Sara ^a   Pashaei Asl, Roghiyeh ^b   Khandaghi, Amir Ahmad ^b   Nasrabadi, Hamid Tayefi ^b   Nejati Koshki, Kazem ^b   Akbarzadeh, Abolfazl ^a,b   Joo, Sang Woo ^c   Hanifehpour, Younes ^b,c   Davaran, Soodabeh ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Yeungnam University   (South Korea)

Author keywords

oral delivery; pH sensitivity; PLGA PEG insulin

Indexed keywords

INSULIN; MACROGOL; MACROGOL 2000; MACROGOL 4000; NANOPARTICLE; POLYGLACTIN; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CHEMICAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; HYDROGEL; IN VITRO STUDY; INFRARED SPECTROMETRY; MOLECULAR WEIGHT; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMISTRY; DIABETES MELLITUS; HUMAN; ORAL DRUG ADMINISTRATION; SYNTHESIS;

ADMINISTRATION, ORAL; DIABETES MELLITUS; DRUG CARRIERS; HUMANS; HYDROGEN-ION CONCENTRATION; INSULIN; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID;

EID: 84905913947     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.13504     Document Type: Erratum

References (47)

1. Gowthamarajan K., Kulkarni G.T., (2003) Resonance. 38-46.
2. Kumar M.T., Willi P., Chandra P., Sharma Kuriachan M.A., (2005) Trends biomater. Artif Organs; 18: 198-202.
3. Nakamura K., Murray R.J., Joseph J.I., Peppas N.A., Morishita M., Lowman A.M., (2004) Preparation and Characterization of Poly-caprolactone Particles for Controlled Insulin Delivery. J Cont Release; 95: 589-599.
4. Sajeesh S., Sharma C.P., (2006) Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm; 325: 147-54.
5. Jain D., Panda A.K., Majumdar D.K., (2005) Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech; 6: E100-7.
6. Lyer H., Khedkar A., Verma M., (2010) Oral insulin-a review of current status. Diabetes Obes Metab; 12: 179-185.
7. Davaran S., Rafie F., Jafari B., (2011) Oral insulin: A review on its current condition and future aspects. Pharm Sci; 17: 151-162.
8. Liu F.Y., Shao Z., Kildsig D.O., Mitra A.K., (1993) Delivery technologies for biopharmaceuticals: peptides, proteins, nucleic acids. Pharm Res; 10: 228-232.
9. Golomb G., Avramoff A., Hoffman A., (1993) Therapeutic peptides and proteins: formulation, process and development systems. Pharm Res; 10: 828-833.
10. Aungst B.J., (1994) Protein delivery: physical systems. Int J Pharm; 105: 219-225.
11. Shojaei A.H., (1998) Buccal mucosa as a route for systemic drug delivery. J Pharm Pharm Sci; 1: 15-30.
12. Siddiqui O., Sun Y., Liu J.C., Chien Y.W., (1987) Passive and iontophoretic transport enhancement of insulin through porcine epidermis by depilatories: Permeability and fourier transform infrared spectroscopy studies. J Pharm Sci; 76: 341-345.
13. Agarwal V., Khan M.A., (2001) Current status of the oral delivery of insulin. Pharm Technol; 25: 76-90.
14. Lee V.H.L., editor. (1991) Enzymatic barriers to protein and peptide drug delivery. In: Protein and Peptide Drug Delivery Encyclopedia of pharmaceutical technology, New York, NY: Marcel Dekker. Chapter 7.
15. Vugmeyster Y., Xu X., Theil F.-P., Khawli L.A., Leach M.W., (2012) Pharmacokinetics and toxicology of therapeutic proteins: advances and challenges. World J Biol Chem; 3: 73-92.
16. Grillberger L., Kreil T.R., Nasr S., Reiter M., (2009) Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells. Biotechnol J; 4: 186-201.
17. Miller W.L., Baxter J.D., (1980) Recombinant DNA-A new source of insulin. Diabetologia; 18: 431-436.
18. Peracchia M.T., Vauthier C., Passirani C., Couvreur P., Labarre D., (1997) Complement consumption by poly(ethylene glycol)in different conformations chemically coupled to poly-(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci; 61: 749-761.
19. Stolnik S., Dunn S.E., Garnett M.C., Davies M.C., Coombes A.G.A., Taylor D.C., Irving M.P., Purkiss S.C., Tadros T.F., Davis S., Illum L., (1994) Surface modification of poly(lac-tide-co-glycolide) nanoparticles by biodegradable poly(lac- tide)-poly(ethylene glycol) copolymer. Pharm Res; 11: 1800-1808.
20. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., Veillard M., (1995) Stealth me PEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte system. J Pharm Sci; 84: 493-498.
21. Jafari B., Rafie F., Davaran S., (2011) Preparation and characterization of a novel smart polymeric hydrogel for drug delivery of insulin. Bioimpacts; 1: 135-143.
22. Gref R., Minamitake Y., Perracchia M.T., Trubetskoy V., Torchilin V., Langer R., (1994) Biodegradable long-circulating poly-mericnanospheres. Science; 263: 1600-1603.
23. Stolnik S., Illum L., Davis S.S., (1995) Long circulating microparticulate drug carriers. Adv Drug Del Rev; 16: 195-214.
24. Savva M., Duda E., Huang L., (1999) A genetically modified recombinant tumor necrosis factor-alpha conjugated to the distal terminals of liposomal surface grafted poly-ethyleneglycol chains. Int J Pharm; 184: 45-51.
25. Tobio M., Gref R., Sanchez A., Langer R., Alonso M.J., (1998) Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res; 15: 270-275.
26. Lamprecht A., Ubrich N., Hombreiro Perez M., Lehr C.-M., Hoffman M., Maincent P., (1999) Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int J Pharm; 184: 97-105.
27. Iwata M., McGinity J.W., (1992) Preparation of multi-phase microspheres of poly (lactic acid) and poly (lactic-co-glycolic acid) containing a W/O emulsion by a multiple solvent evaporation technique. J Microencapsulation; 9: 201-214.
28. Blanco M.D., Alonso M.J., (1997) Development and characterization of protein-loaded poly (lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm; 43: 287-294.
29. Lemoine D., Preat V., (1998) Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J Control Release; 54: 15-27.
30. Peterson P.L., (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem; 83: 346-356.
31. Hrkach J.S., Peracchia M.T., Domb A., Lotan N., Langer R., (1997) Nanotechnology for biomaterials engineering: structura characterization of amphiphilic polymeric nanoparticles by 1H-NMR spectroscopy. Biomaterials; 18: 27-30.
32. Armstrong T.I., Davies M.C., Illum L., (1997) Human serum albumin as a probe for protein adsorption to nanoparticles. J Drug Target; 4: 389-398.
33. Park T.G., (1994) Degradation of poly (DL-lactic) microsphere: effect of molecular weight. J Control Release; 30: 161-173.
34. Oh J.E., Nam Y.S., Lee K.H., Park T.G., (1999) Conjugation of drug to poly(DL-lactic-co-glycolic acid) for controlled release from biodegradable microspheres. J Control Release; 57: 269-280.
35. Yoo H.S., Park T.G., (2000) In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release; 68: 419-431.9.
36. Akbarzadeh A., Zarghami N., Mikaeili H., Asgari D., Goganian A.M., Khiabani K., Samiei M., Davaran S., (2012) Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnol Sci Appl; 5: 1-13.
37. Akbarzadeh A., Mikaeili H., Zarghami N., Mohammad R., Bsrkhordari A., Davaran S., (2012) Preparation and in-vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymer. Int J Nanomed; 7: 1-16.
38. Akbarzadeh A., Samiei M., Davaran S., (2012) Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett; 7: 144.
39. Valizadeh A., Mikaeili H., Samiei M., Farkhani S.M., Zarghami N., Kouhi M., Akbarzadeh A., Davaran S., (2012) Quantum dots: synthesis, bioapplications, and toxicity Nanoscale. Res Lett; 7: 480.
40. Akbarzadeh A., Samiei M., Joo S.W., Anzaby M., Hanifehpour Y., Nasrabadi H.T., (2012) Davaran, synthesis, characterization and in vitro studies of doxorubicin- loaded magnetic nanoparticles grafted to smart copo- lymers on A549 lung cancer cell line. J Nanobiotechnol; 10: 46.
41. Akbarzadeh A., Rezaei-Sadabady R., Davaran S., Joo S.W., Zarghami N., Hanifehpour Y., Samiei M., Kouhi M., Nejati-Koshki K., (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett; 8: 102.
42. Pourhassan-Moghaddam M., Rahmati-Yamchi M., Ak- barzadeh A., Daraee H., Nejati-Koshki K., Hanifehpour Y., Joo S.W., (2013) Protein Detection through Different Plat- forms of Immuno-Loop-Mediated Isothermal Amplifica- tion. Nanoscale Res Lett; 8: 485.
43. Mollazade M., Nejati-Koshki K., Akbarzadeh A., Ha- nifehpour Y., Zarghami N., Joo S.W., (2013) PAMAM Den- drimers arguement inhibitory effect of curcumin on can- cer cell proliferation: possible inhibition of telomerase.
44. Ghasemali S., Akbarzadeh A., Alimirzalu S., Rahmati Yamchi M., Barkhordari A., Tozihi M., Kordi S.H., et al,. (2013) Study of inhibitory effect of β-Cyclo- dextrin-helenalin complex on HTERT gene expression in T47D breast cancer cell line by real time quantitative PCR (q-PCR).
45. Nejati-Koshki K., Akbarzadeh A., Pourhasan-Mogha- dam M., Joo S.W., (2013) Inhibition of leptin and leptin re- ceptor gene expression by Silibinin-Curcumin Combina-tion.
46. Rezaei-Sadabady R., Zarghami N., Barzegar A., Eidi A., Akbarzadeh A., Rezaei-Tavirani M., (2013) Studies of the relationship between structure and antioxidant activity in interesting systems, including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. Soft; 2: 13-18.
47. Ebrahimnezhad Z., Zarghami N., Keyhani M., Amirsa- adat S., Akbarzadeh A., Rahmati M., Taheri Z.M., (2013) Nejati-Koshki K. Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. Bioimpacts; 3: 67-74.